WebMar 13, 2024 · Background This meta-analysis aimed to assess the performance of the CRAFITY (CRP and AFP in immunotherapy) score as a prognostic factor in hepatocellular carcinoma (HCC) treated with immunotherapy. Methods The PubMed, Cochrane Library, and Web of Science databases were searched for published studies. Hazard ratios … WebJun 10, 2024 · 有学者基于两项临床常用实验室指标,C反应蛋白(CRP)和甲胎蛋白(AFP),构建了CRAFITY评分模型 [1],该评分可快速、精准预测肝癌免疫治疗疗效, …
The CRAFITY score: A promising prognostic predictor for ... - PubMed
WebThe CRAFITY score: A new guidepost for prognosis prediction in patients with hepatocellular carcinoma undergoing immunotherapy. ... 中文翻译: CRAFITY 评分:接受免疫治疗的肝细胞癌患者预后预测的新指南。 更新日期:2024-01-18 点击分享 查看原文 点击收藏 取消收藏. 阅读更多本刊最新论文 ... WebThe CRAFITY score: A new guidepost for prognosis prediction in patients with hepatocellular carcinoma undergoing immunotherapy. J Hepatol. 2024 Jan 18;S0168 … roman outline font
Prognosis of patients with hepatocellular carcinoma treated …
WebMar 13, 2024 · Background: This meta-analysis aimed to assess the performance of the CRAFITY (CRP and AFP in immunotherapy) score as a prognostic factor in hepatocellular carcinoma (HCC) treated with immunotherapy. Methods: The PubMed, Cochrane Library, and Web of Science databases were searched for published studies. Hazard ratios … WebMar 13, 2024 · Combination CRAFITY score and AFP response at 6 weeks with AUROC predicts OS and tumor response to be 0.809 and 0.798, respectively, better than either … Web至于关键的crafity评分,则由检测到的afp和crp值确定,具体如下: crafity评分标准. 在基线特征方面,crafity评分为1分或2分的患者相比,crafity评分为0分的患者显示出更好的体力评分、更好的肝功能、一线 … roman pachta